These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9091511)

  • 41. Clinical pharmacokinetics of the retinoids.
    Lucek RW; Colburn WA
    Clin Pharmacokinet; 1985; 10(1):38-62. PubMed ID: 3882304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical delivery system for tretinoin: research and clinical implications.
    Skov MJ; Quigley JW; Bucks DA
    J Pharm Sci; 1997 Oct; 86(10):1138-43. PubMed ID: 9344171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tretinoin emollient cream: a new therapy for photodamaged skin.
    Olsen EA; Katz HI; Levine N; Shupack J; Billys MM; Prawer S; Gold J; Stiller M; Lufrano L; Thorne EG
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):215-24. PubMed ID: 1552056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
    Rizvi NA; Marshall JL; Ness E; Yoe J; Gill GM; Truglia JA; Loewen GR; Jaunakais D; Ulm EH; Hawkins MJ
    Clin Cancer Res; 1998 Jun; 4(6):1437-42. PubMed ID: 9626460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained improvement in photodamaged skin with reduced tretinoin emollient cream treatment regimen: effect of once-weekly and three-times-weekly applications.
    Olsen EA; Katz HI; Levine N; Nigra TP; Pochi PE; Savin RC; Shupack J; Weinstein GD; Lufrano L; Jou HC
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):227-30. PubMed ID: 9270508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variability in the oral bioavailability of all-trans-retinoic acid.
    Adamson PC; Pitot HC; Balis FM; Rubin J; Murphy RF; Poplack DG
    J Natl Cancer Inst; 1993 Jun; 85(12):993-6. PubMed ID: 8388479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters.
    Eckhoff C; Willhite CC
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):79-87. PubMed ID: 9299599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey.
    Adamson PC; Murphy RF; Godwin KA; Ulm EH; Balis FM
    Cancer Res; 1995 Feb; 55(3):482-5. PubMed ID: 7834612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of plasma and tissue distribution of 9-cis-retinoic acid in rat.
    Disdier B; Marchetti MN; Bun H; Placidi M; Durand A
    Skin Pharmacol Appl Skin Physiol; 2000; 13(1):9-16. PubMed ID: 10657762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An in vivo experimental model for effects of topical retinoic acid in human skin.
    Griffiths CE; Finkel LJ; Tranfaglia MG; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1993 Oct; 129(4):389-94. PubMed ID: 8217750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of 13-cis-, all-trans-, 13-cis-4-oxo-, and all-trans-4-oxo retinoic acid after intravenous administration in the cynomolgus monkey.
    Sandberg JA; Eckhoff C; Nau H; Slikker W
    Drug Metab Dispos; 1994; 22(1):154-60. PubMed ID: 8149876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of photodamage with topical tretinoin: an overview.
    Gilchrest BA
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S27-36. PubMed ID: 9091506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
    Adamson PC; Widemann BC; Reaman GH; Seibel NL; Murphy RF; Gillespie AF; Balis FM
    Clin Cancer Res; 2001 Oct; 7(10):3034-9. PubMed ID: 11595692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is topical tretinoin safe during the first trimester?
    Shapiro L; Pastuszak A; Curto G; Koren G
    Can Fam Physician; 1998 Mar; 44():495-8. PubMed ID: 9559187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.
    Rigas JR; Francis PA; Muindi JR; Kris MG; Huselton C; DeGrazia F; Orazem JP; Young CW; Warrell RP
    J Natl Cancer Inst; 1993 Dec; 85(23):1921-6. PubMed ID: 8230282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing the bioequivalence of topical retinoid products by pharmacodynamic assay.
    Lehman PA; Franz TJ
    Skin Pharmacol Physiol; 2012; 25(5):269-80. PubMed ID: 22847319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. All-trans-retinoic acid and 13-cis-retinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes.
    Schroeder M; Zouboulis CC
    Horm Metab Res; 2007 Feb; 39(2):136-40. PubMed ID: 17326009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical retinoids in acne--an evidence-based overview.
    Thielitz A; Abdel-Naser MB; Fluhr JW; Zouboulis CC; Gollnick H
    J Dtsch Dermatol Ges; 2008 Dec; 6(12):1023-31. PubMed ID: 18479477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group.
    Wadler S; Schwartz EL; Anderson P; Runowicz CD; Chuang L; Del Priore G; Hochster H; Goldberg G; Fields A; Loewen G; Haynes H
    Cancer J Sci Am; 1999; 5(3):165-70. PubMed ID: 10367173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.